Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

48.31
+0.29790.62%
Post-market: 48.22-0.0881-0.18%19:30 EDT
Volume:735
Turnover:35.43K
Market Cap:31.40M
PE:- -
High:48.31
Open:48.29
Low:48.22
Close:48.01
52wk High:57.44
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.63
T/O Rate:0.11%
Dividend:0.36
Dividend Rate:0.75%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck Says Remigromig Meets Primary Endpoint in Brunello Diabetic Macular Edema Trial at One Year

Reuters
·
2 hours ago

Merck Presents One-Year Results from the Pivotal Phase 2B/3 Brunello Study Evaluating Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at Aao 2026

THOMSON REUTERS
·
2 hours ago

Merck & Co - Remigromig Demonstrates Non-Inferior Visual Acuity Versus Ranibizumab at One Year in Dme

THOMSON REUTERS
·
2 hours ago

Research Reports

Dow Jones
·
Yesterday

Zoetis Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
Yesterday

Merck & Company (MRK) Receives a Buy from UBS

TIPRANKS
·
Oct 09

Merck price target lowered to $163 from $166 at BofA

TIPRANKS
·
Oct 09

Wells Fargo Adjusts Price Target on Merck & Co to $165 From $170

MT Newswires Live
·
Oct 09

Zoetis (ZTS) Gets A Fresh Heartworm Boost While Fair Value Stays In Focus

Simply Wall St.
·
Oct 09

Zoetis Declares Fourth-Quarter Dividend, Signals Ongoing Strength

TIPRANKS
·
Oct 09

Press Release: Zoetis Declares Fourth Quarter 2026 Dividend

Dow Jones
·
Oct 09

Zoetis put volume heavy and directionally bearish

TIPRANKS
·
Oct 09

Merck & Company (MRK) Receives a Buy from BMO Capital

TIPRANKS
·
Oct 08

A Partnership for Pets: Simon Cowell and Trupanion Team Up

GlobeNewswire
·
Oct 08

Health Care up on Defensive Bias

Dow Jones
·
Oct 08

Sector Update: Healthcare

MT Newswires Live
·
Oct 08

Moderna, Merck Climb on Collaboration with Tempus

Reuters
·
Oct 08

Merck's Keytruda is Dealt a Legal Setback. It's Good News for This Biotech Stock.

Dow Jones
·
Oct 08